Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Sex Differences, Cognitive Training & Emotion Processing: Complete Statistical AnalysisIndependent statistical analysis of Sex Differences, Cognitive Training & Emotion Processing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03137654).
- Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid: Complete Statistical AnalysisIndependent statistical analysis of Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sexual Function and Wellbeing in Males With Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sexual Function and Wellbeing in Males With Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01216202).
- SFA ISRIndependent statistical analysis of Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SFPATIndependent statistical analysis of Sinusitis and Facial Pain Disorders Anti-Depression Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00754793).
- SGA-induced Metabolic Syndrome in Bipolar Youth: Complete Statistical AnalysisIndependent statistical analysis of SGA-induced Metabolic Syndrome in Bipolar Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01858948).
- SGA-POWERIndependent statistical analysis of Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SGI-110Independent statistical analysis of SGI-110 in Combination With Carboplatin in Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01696032).
- SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction: Complete Statistical AnalysisIndependent statistical analysis of SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot: Complete Statistical AnalysisIndependent statistical analysis of SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SGLT2iIndependent statistical analysis of SGLT2 Inhibition in Older Obese Adults With Pre-diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04401904).
- SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study: Complete Statistical AnalysisIndependent statistical analysis of SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SH-DS01 on Fecal Metagenomic Stability: Complete Statistical AnalysisIndependent statistical analysis of SH-DS01 on Fecal Metagenomic Stability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04598295).
- SHAPEIndependent statistical analysis of Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00608062).
- ShaperonIndependent statistical analysis of A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SHARE Project Define: Complete Statistical AnalysisIndependent statistical analysis of SHARE Project Define: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06125509).
- Shared Decision Making About Medication Use for People With Multiple Health Problems: Complete Statistical AnalysisIndependent statistical analysis of Shared Decision Making About Medication Use for People With Multiple Health Problems: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Shared Decision Making in Parents of Children With Head Trauma: Head CT Choice: Complete Statistical AnalysisIndependent statistical analysis of Shared Decision Making in Parents of Children With Head Trauma: Head CT Choice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Shared Healthcare Actions and Reflections Electronic Systems in Survivorship: Complete Statistical AnalysisIndependent statistical analysis of Shared Healthcare Actions and Reflections Electronic Systems in Survivorship: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04337203).
- SHAREDCareIndependent statistical analysis of Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SHARESIndependent statistical analysis of Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SHARPIndependent statistical analysis of SHARP, the randomized phase 3 study of sorafenib versus placebo in patients with advanced hepatocellular carcinoma, including its overall survival and symptomatic progression endpoints, stratified log-rank methodology, interim…
- SHARPIndependent statistical analysis of Efficacy of a Multimodal Brain Health Intervention for Older African Americans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SHARPIndependent statistical analysis of SpHincterotomy for Acute Recurrent Pancreatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03609944).
- SHARPIndependent statistical analysis of Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SHARPENIndependent statistical analysis of SHARPEN - Parkinson's Disease Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05987540).
- SHARPSIndependent statistical analysis of Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Shear Wave Sonoelastography in Pediatric Liver Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Shear Wave Sonoelastography in Pediatric Liver Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02372682).
- SHELTERIndependent statistical analysis of Transplanting Hepatitis C Lungs Into Negative Lung Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03724149).
- SHIELDIndependent statistical analysis of 38 Week Extension Study to CAIN457C2303: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01093846).
- SHIELDIndependent statistical analysis of Phase III Study in Refractory Behcet's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00995709).
- SHIELD-4Independent statistical analysis of An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SHIFTIndependent statistical analysis of Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study: primary endpoint results,…
- Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico: Complete Statistical AnalysisIndependent statistical analysis of Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06250738).
- Shifting Rehabilitation Paradigms in Skilled Nursing Facilities: Complete Statistical AnalysisIndependent statistical analysis of Shifting Rehabilitation Paradigms in Skilled Nursing Facilities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02927171).
- Shifting Salty Taste Preferences in Children: Complete Statistical AnalysisIndependent statistical analysis of Shifting Salty Taste Preferences in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02909764).
- Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection: Complete Statistical AnalysisIndependent statistical analysis of Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SHINEIndependent statistical analysis of A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SHINEIndependent statistical analysis of Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SHINEIndependent statistical analysis of Randomized Controlled Clinical Trial of Weight Loss Programs in Obese Persons: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SHiPIndependent statistical analysis of Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study: Complete Statistical AnalysisIndependent statistical analysis of SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi: Complete Statistical AnalysisIndependent statistical analysis of ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Shockwave Coronary Lithoplasty® Study (Disrupt CAD II): Complete Statistical AnalysisIndependent statistical analysis of Shockwave Coronary Lithoplasty® Study (Disrupt CAD II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03328949).
- Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I): Complete Statistical AnalysisIndependent statistical analysis of Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02650128).
- SHoPPERIndependent statistical analysis of Study of Household Purchasing Patterns, Eating and Recreation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02073643).
- ShOReIndependent statistical analysis of OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04757610).
- Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children: Complete Statistical AnalysisIndependent statistical analysis of Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Short Term Follow-up of a Botulinum Toxin Intervention in Children With Spastic Cerebral Palsy: Complete Statistical AnalysisIndependent statistical analysis of Short Term Follow-up of a Botulinum Toxin Intervention in Children With Spastic Cerebral Palsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…